Exposure to BPA might lessen chances of successful pregnancy, research suggests
THURSDAY, Nov. 13 (HealthDay News) -- Bisphenol A, a controversial chemical used to harden plastic packaging for many foods and beverages, may affect human reproduction, researchers report.
Bisphenol A (BPA) could hurt the chances of successful in vitro fertilization, or the ability of embryos to attach to the uterus, according to presentations at the American Society for Reproductive Medicine's annual meeting, which concluded Wednesday in San Francisco.
"The issue of environmental toxicants upon human reproduction is very important," said Dr. Richard J. Paulson, chief of the Division of Reproductive Endocrinology and Infertility at the University of Southern California Keck School of Medicine, who was not involved in the studies.
Last month, a U.S. Food and Drug Administration advisory panel said the agency had erred when it said that BPA, which is widely used in baby bottles and other plastic packaging for foods and beverages, posed no health risks. The agency said it would probably start research early in 2009 to determine the toxic effects of BPA on babies less than 1 month old.
In the first report, a team led by Dr. Julie Lamb, of the University of California, San Francisco, measured levels of BPA in people going through their first cycle of in vitro fertilization (IVF). Ninety-three percent of the 41 women had measurable BPA levels; among the 31 men, 81 percent had quantifiable levels of the chemical.
The researchers also found there was a small trend among women with measurable BPA levels not to become pregnant.
Paulson doesn't think this finding is proof that BPA can affect the chances of successful in vitro fertilization.
"Most of the women had detectable levels of BPA, indicating that BPA is definitely in the circulation of women undergoing fertility treatment," he said. "However, the significance of this finding is as yet uncertain."
In another presentation, Dr. Shelley Ehrlich of the Harvard School of Public Health and colleagues found that exposure to BPA did not affect semen quality. The researchers looked at BPA levels in the semen of 71 men and evaluated the quality of the semen.
Paulson said this finding was "reassuring, although the authors do caution that the study was small, and the results should be considered preliminary."
Commenting on these two studies, Dr. Hugh S. Taylor, director of the Division of Reproductive Endocrinology and Infertility at the Yale University School of Medicine, noted that the findings didn't reach the level of statistical significance.
"This is not where I suspected to find the defects related to BPA," Taylor said. "BPA seems more powerful as a developmental toxicant," he said, referring to fetal and early childhood development.
In the third study, Dr. Lusine Aghajanova, a postdoctoral fellow at the University of California, San Francisco, exposed uterine cells obtained from healthy women to BPA in a range of doses found in the U.S. population.
"We observed that even short-term exposure of those uterine cells to BPA significantly decreases the division of cells," Aghajanova said. "Moreover, our data suggest that BPA can interfere with further development of uterine cells and the way they change in preparation for possible pregnancy."
Exposure to BPA may prevent the embryo from attaching to the uterus, Aghajanova said.
Previous animal experiments have suggested that BPA may mimic the female sex hormone estrogen. The worry has been that exposure to the chemical can cause birth defects and developmental problems in children.
Exposure to BPA also has been suspected of causing a variety of other health problems, including cancer, diabetes, obesity and attention-deficit disorder. BPA exposure can occur through direct contact with the chemical or by exposure to food or drink that has been in contact with material containing BPA.
To learn more about BPA, visit the U.S. National Institute of Environmental Health Sciences.
SOURCES: Lusine Aghajanova, M.D., Ph.D., postdoctoral fellow, University of California, San Francisco; Hugh S. Taylor, M.D., director, division of reproductive endocrinology and infertility, and professor, obstetrics and gynecology, Yale University School of Medicine, New Haven, Conn.; Richard J. Paulson, M.D., professor, obstetrics and gynecology, and chief, division of reproductive endocrinology and infertility, University of Southern California Keck School of Medicine, Los Angeles; Nov. 11, 2008, presentations, American Society for Reproductive Medicine annual meeting, San Francisco
All rights reserved